Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin

Diabetologia

Volumn 57, Issue 5, 2014, Pages 950-959

  Brom, Maarten ^a   Woliner Van Der Weg, Wietske ^a   Joosten, Lieke ^a   Frielink, Cathelijne ^a   Bouckenooghe, Thomas ^b,c   Rijken, Paul ^a   Andralojc, Karolina ^a   Göke, Burkhard J ^d   De Jong, Marion ^e   Eizirik, Decio L ^b   Béhé, Martin ^f,g   Lahoutte, Tony ^h   Oyen, Wim J G ^a   Tack, Cees J ^a   Janssen, Marcel ^a   Boerman, Otto C ^a   Gotthardt, Martin ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d UNIVERSITY OF MUNICH   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF FREIBURG   (Germany)

^g ETH Zurich   (Switzerland)

^h VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Beta cell mass; Exendin; Glucagon like peptide 1 receptor; Single photon emission computed tomography

Indexed keywords

EXENDIN IN 111; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INDIUM 111; INSULIN ANTIBODY; UNCLASSIFIED DRUG; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HELOSPECTIN I; INDIUM; PEPTIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; YOUNG ADULT; ADOLESCENT; ANIMAL; BLOOD; DIAGNOSTIC USE; METABOLISM; PROCEDURES; SCINTISCANNING; TIME;

ADOLESCENT; ADULT; ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PEPTIDES; RADIOPHARMACEUTICALS; RATS; RECEPTORS, GLUCAGON; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84898601980     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3166-3     Document Type: Article

References (46)

1. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43-S48
2. Lohr M, Kloppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757-762 (Pubitemid 17163000)
3. Steele C, Hagopian WA, Gitelman S et al (2004) Insulin secretion in type 1 diabetes. Diabetes 53:426-433 (Pubitemid 38174559)
4. Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51-60
5. Klinke DJ 2nd (2008) Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PloS ONE 3:e1374 (Pubitemid 351223142)
6. Couri CE, Oliveira MC, Stracieri AB et al (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301:1573-1579
7. DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269
8. Taylor SI (1999) Deconstructing type 2 diabetes. Cell 97:9-12 (Pubitemid 29165884)
9. Weir GC, Bonner-Weir S (2004) Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53(Suppl 3):S16-S21 (Pubitemid 39564517)
10. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97-S107 (Pubitemid 43343337)
11. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110 (Pubitemid 36042113)
12. Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC (2006) Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29:717-718 (Pubitemid 44115384)
13. Korner M, Stockli M, Waser B, Reubi JC (2007) GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736-743 (Pubitemid 47604973)
14. Tornehave D, Kristensen P, Romer J, Knudsen LB, Heller RS (2008) Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem 56:841-851
15. Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC (2010) 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 37:1345-1355
16. Wang Y, Lim K, Normandin M, Zhao X, Cline GW, Ding YS (2012) Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic beta-cell mass. Nucl Med Biol 39:167-176
17. Wild D, Wicki A, Mansi R et al (2010) Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT. J Nucl Med 51:1059-1067
18. Wu Z, Liu S, Hassink M et al (2013) Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med 54:244-251
19. Wu Z, Todorov I, Li L et al (2011) In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor. Bioconjug Chem 22:1587-1594
20. Heskamp S, van Laarhoven HW, Molkenboer-Kuenen JD et al (2010) ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model. J Nucl Med 51:1565-1572
21. Rademakers SE, Rijken PF, Peeters WJ et al (2011) Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers. Cell Oncol (Dordr) 34:119-129
22. Rijken PF, Bernsen HJ, van der Kogel AJ (1995) Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 50:141-153
23. Garofano A, Czernichow P, Breant B (1998) Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 41:1114-1120 (Pubitemid 28394419)
24. Chen CM, Behringer RR (2001) Cloning, structure, and expression of the mouse Ovca1 gene. Biochem Biophys Res Commun 286:1019-1026 (Pubitemid 32924873)
25. Cunha DA, Hekerman P, Ladriere L et al (2008) Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J Cell Sci 121:2308-2318
26. Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312 (Pubitemid 29213178)
27. Nock BA, Nikolopoulou A, Galanis A et al (2005) Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. J Med Chem 48:100-110 (Pubitemid 40109510)
28. Maina T, Nock BA, Zhang H et al (2005) Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs. J Nucl Med 46:823-830
29. Jensen RT, Moody T, Pert C, Rivier JE, Gardner JD (1978) Interaction of bombesin and litorin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A 75:6139-6143 (Pubitemid 9100962)
30. Moran TH, Moody TW, Hostetler AM, Robinson PH, Goldrich M, McHugh PR (1988) Distribution of bombesin binding sites in the rat gastrointestinal tract. Peptides 9:643-649 (Pubitemid 19268158)
31. Brom M, Joosten L, Oyen WJ, Gotthardt M, Boerman OC (2012) Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas. Contrast Media Mol Imaging 7:160-166
32. Reiner T, Thurber G, Gaglia J et al (2011) Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci U S A 108:12815-12820
33. Xu G, Kaneto H, Lopez-Avalos MD, Weir GC, Bonner-Weir S (2006) GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract 73:107-110 (Pubitemid 43765553)
34. Brom M, Andralojc K, Oyen WJ, Boerman OC, Gotthardt M (2010) Development of radiotracers for the determination of the beta-cell mass in vivo. Curr Pharm Des 16:1561-1567
35. Xu G, Kaneto H, Laybutt DR et al (2007) Downregulation of GLP-1 and GIP receptor expression by hyperglycemia - possible contribution to impaired incretin effects in diabetes. Diabetes 56:1551-1558 (Pubitemid 46842610)
36. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10(Suppl 4):32-42
37. Moore A, Bonner-Weir S, Weissleder R (2001) Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes. Diabetes 50:2231-2236 (Pubitemid 33641906)
38. Freeby M, Goland R, Ichise M, Maffei A, Leibel R, Harris P (2008) VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab 10(Suppl 4):98-108
39. Goland R, Freeby M, Parsey R et al (2009) 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 50:382-389
40. de Lonlay P, Simon-Carre A, Ribeiro MJ et al (2006) Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 91:933-940 (Pubitemid 43357761)
41. Hardy OT, Hernandez-Pampaloni M, Saffer JR et al (2007) Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr 150:140-145 (Pubitemid 46127552)
42. Otonkoski T, Nanto-Salonen K, Seppanen M et al (2006) Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 55:13-18 (Pubitemid 43343294)
43. Rubi B, Ljubicic S, Pournourmohammadi S et al (2005) Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 280:36824-36832 (Pubitemid 41587763)
44. Sweet IR, Cook DL, Lernmark A et al (2004) Systematic screening of potential beta-cell imaging agents. Biochem Biophys Res Commun 314:976-983 (Pubitemid 38142379)
45. Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using F-18-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908-916
46. Freeby M, Ichise M, Harris PE (2012) Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas. Islets 4:393-397